Category: Uncategorized

HEXO’s (HEXO) earnings report last week showcased muscular strength and drive to gain a top position within the cannabis industry and CEO Sebastien St-Louis clearly is fixated on getting there through all means necessary. The company is also an absolute steal right now at a sub $900M market cap, especially when compared to their competitors:… Continue reading 20Mar21: HEXO Aims for Top 2

The third Friday of each month is already a special time for the market because that is when equity and index options usually expire, so there’s extra volume/volatility. And then periodically we have a supercharged version: Triple Witching — Triple witching is the simultaneous expiration of stock options, stock index futures and stock index options… Continue reading 19Mar21: Triple Witching Day

The Canadian cannabis company HEXO (HEXO) got beat up last year and at one point plummeted to well under a $500M market cap. After performing a reverse split, tightening up operations and forging ahead on their mission of becoming one of Canada’s top cannabis companies, they announced this morning a positive adjusted EBITDA and that… Continue reading 18Mar21: HEXO, Phoenix Rising

The data-driven marketing services company Fluent (FLNT) had a decent earnings report yesterday and their current sell-off is due to weaker projected guidance. But there is good reason for the softer outlook for next quarter: they are onboarding some significant new brands (adding 3 to their existing 2) to now be working with 5 of… Continue reading 17Mar21: Fluent Levels Up

COVID and cancer pose monumental challenges to research scientists working diligently to solve these epic problems and Cambridge has become a hotbed of activity within the burgeoning biotech industry. Moderna (MRNA) took a lead position among the COVID vaccine manufacturers and has a whole host of messenger RNA therapeutics in the works. During the last… Continue reading 16Mar21: Cambridge’s Biotech Brain Trust

More and more time is being spent on digital devices through phones, tablets, laptops and increasingly smart TVs (CTV). The rub for agencies/brands is how to cut through the noise and competition to reach consumers, especially on smaller screens. As Nicholas Rossolillo explains on the Motley Fool, Digital Turbine (APPS) works directly with device and… Continue reading 15Mar21: Digital Turbine Keeps Turning

The recent Oprah interview with Harry and Meghan sent a thunderbolt strike to the girding of British royal order. Longstanding TV personality (and harsh critic of Meghan Markle) Piers Morgan was quickly dispatched from the airwaves and an expedited reckoning of the Black Lives Matter movement suddenly arrived in the UK. Like many major power… Continue reading 14Mar21: UK’s Projected Power

An individual stock portfolio, if well diversified, is just a small analog of what mutual fund companies like Vanguard bundle together. The advantage of a well curated mix is you have a good chance of not only beating the market overall, but also those targeted mutual funds assembled by the pros. On the 10th of… Continue reading 13Mar21: ADP “Mutual Fund”

The biotech company Novavax (NVAX) announced yesterday that their COVID-19 vaccine candidate is 96.4% effective in phase 3 trial in the UK and 86% effective against the more contagious virus variant. This is huge and the stock should jump accordingly. “Don’t let yesterday take up too much of today.” –Will Rogers

Short and sweet. We are in the midst of a large rebound from last week’s implosion, which will only be further accelerated today by the passing of Biden’s stimulus bill. Lots of deals to be had, but these six below will jump back the fastest. PubMatic (PUBM) Kubient (KBNT) Perion (PERI) Digital Turbine (APPS) Magnite… Continue reading 11Mar21: PSA Buy Alert